Compare VHI & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VHI | XOMA |
|---|---|---|
| Founded | 1932 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 370.5M | 326.5M |
| IPO Year | N/A | N/A |
| Metric | VHI | XOMA |
|---|---|---|
| Price | $14.40 | $26.73 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $12.00 | ★ $63.25 |
| AVG Volume (30 Days) | 24.9K | ★ 731.1K |
| Earning Date | 03-05-2026 | 03-16-2026 |
| Dividend Yield | ★ 2.23% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.65 | ★ 0.82 |
| Revenue | ★ $2,063,400,000.00 | $47,106,000.00 |
| Revenue This Year | $22.20 | $77.29 |
| Revenue Next Year | $7.66 | $29.30 |
| P/E Ratio | ★ $22.23 | $32.50 |
| Revenue Growth | N/A | ★ 118.02 |
| 52 Week Low | $11.44 | $18.35 |
| 52 Week High | $25.25 | $39.92 |
| Indicator | VHI | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 59.37 | 46.63 |
| Support Level | $13.29 | $25.62 |
| Resistance Level | $14.94 | $28.60 |
| Average True Range (ATR) | 0.86 | 2.26 |
| MACD | 0.15 | 0.07 |
| Stochastic Oscillator | 64.00 | 37.87 |
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.